Based in Stony Brook, New York, Dr. Elliott Bennett-Guerrero leads the Department of Anesthesiology at Stony Brook Medicine as the vice chair of clinical research and innovation. Concurrent to this role, Dr. Elliott Bennett-Guerrero helps educate the new generation of medical professionals as a professor of anesthesiology.
Full Epub Atlas of Temporomandibular Joint Surgery unriotingasnerrty
This second edition of the Atlas of Temporomandibular Joint Surgery is a major revision of Dr. Quinn's classic work taking into account new procedures equipment and evidencebased findings from the latest research in TMJ treatment. Assuming that readers are familiar with nonsurgical therapies to correct temporomandibular pain and disorders Drs. Quinn and Granquist focus on the surgical remedies for disorders that are beyond conservative treatment. This concise howto surgical atlas guides both the novice and experienced surgeon through the intraarticular and extraarticular procedures that have proven efficacious in the treatment of advanced craniomandibular dysfunction. Chapters take readers through decision making for TMJ surgery diagnostic imaging methods surgical approaches surgery for internal derangements trauma osseous surgical procedures total joint replacement and pathologies.
Regional Anesthesia in the Prevention of Persistent Postsurgical PainEdward R. Mariano, MD
Persistent postsurgical pain (PPSP), or chronic pain that develops after surgery, occurs more frequently than one may expect: up to 50% after relatively common operations. For anesthesiologists, surgeons, and pain physicians, there is an urgent need to discover methods to prevent the development of PPSP which is considered one of the more dreaded adverse outcomes following elective surgery.
Full Epub Atlas of Temporomandibular Joint Surgery unriotingasnerrty
This second edition of the Atlas of Temporomandibular Joint Surgery is a major revision of Dr. Quinn's classic work taking into account new procedures equipment and evidencebased findings from the latest research in TMJ treatment. Assuming that readers are familiar with nonsurgical therapies to correct temporomandibular pain and disorders Drs. Quinn and Granquist focus on the surgical remedies for disorders that are beyond conservative treatment. This concise howto surgical atlas guides both the novice and experienced surgeon through the intraarticular and extraarticular procedures that have proven efficacious in the treatment of advanced craniomandibular dysfunction. Chapters take readers through decision making for TMJ surgery diagnostic imaging methods surgical approaches surgery for internal derangements trauma osseous surgical procedures total joint replacement and pathologies.
Regional Anesthesia in the Prevention of Persistent Postsurgical PainEdward R. Mariano, MD
Persistent postsurgical pain (PPSP), or chronic pain that develops after surgery, occurs more frequently than one may expect: up to 50% after relatively common operations. For anesthesiologists, surgeons, and pain physicians, there is an urgent need to discover methods to prevent the development of PPSP which is considered one of the more dreaded adverse outcomes following elective surgery.
CPSP is a new emerging disease but can be a silent epidemic.
Optimal perioperative management may reduce the incidence of CPSP.
Minimal invasive surgical techniques
Agressive perioperative multimodal analgesia, inluding epidural or nerve blocks.
Appropriate management of acute pain is therefore not only a humane obligation, but also may prevent of chronic pain!
Acute pain management requires a multimodal and multidisciplinary approach with a clear organization framework. Regional anesthesia techniques for surgical anesthesia are a highly effective component of acute pain management.
With the advancement of ultrasonographic technology with higher resolution and penetration imaging, there is increasing use of ultrasonography (US) in acute and chronic pain blocks.
Recently, denervation therapy has been applied clinically for the treatment of intractable osteoarthritis (OA). This therapy provides an alternative for patients who are insensitive to conservative therapies or unwilling to receive surgery and general anesthesia. However, therapeutic effect of this method, especially the long-term efficacy, is still controversial.
Pain Physicians should consider nerve blocks when systemic analgesics are failing. (Adjuvant therapy)
Careful selection of patients
Benefits should outweigh the risks
Thorough knowledge of the limitations and side effects
Need for randomized controlled clinical trials.
Cancer hurts!
The misconception that a cancer patient is doomed to endure pain must be corrected. Cancer has pain and cancer pain has a cure. To manage cancer pain, we need to have a multidisciplinary approach.
Trauma is one of the primary causes of mortality and morbidity worldwide, and pain is the most common symptom reported by patients entering the Emergency Department. More than 5 million people in the United States report long-term disabilities due to traumatic injuries. Safe intraoperative care and effective acute pain management are essential for successful outcomes in the trauma patient.
Total knee replacement (TKR) is one of the most commonly done surgical procedures, with over 150,000 total knee replacements and THR performed annually in England and Wales in the National Health Service (NHS). In India although clear-cut data is not available but the incidence is increasing. In the US, 431,000 TKRs are performed yearly and the utilization of TKR has increased over the last two decades, especially among younger patients .TKR may be associated with severe post-operative pain. The International Association for the Study of Pain (IASP) has defined pain as “an unpleasant sensory or emotional experience associated with actual or potential tissue damage, or described in terms of such damage”. The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has made adequate pain management a priority and has deemed monitoring pain as the “fifth” vital sign.
Management of acute postoperative pain has revolutionized in recent decades. Fortunately, there is a great consensus regarding the benefits of pain control in the immediately postoperative period on morbidity and mortality of the surgical patients. Anaesthesiologists have a key role in this field.
Dr. Alan Kaye Shreveport is a leading Anesthesiologist, Pain Medicine Specialist and Interventional Pain Management Specialist with over 3 decades of experience. He has helped many thousands of people gain relief from acute and chronic pain through proven therapy methods, technology, and his wealth in education.
CPSP is a new emerging disease but can be a silent epidemic.
Optimal perioperative management may reduce the incidence of CPSP.
Minimal invasive surgical techniques
Agressive perioperative multimodal analgesia, inluding epidural or nerve blocks.
Appropriate management of acute pain is therefore not only a humane obligation, but also may prevent of chronic pain!
Acute pain management requires a multimodal and multidisciplinary approach with a clear organization framework. Regional anesthesia techniques for surgical anesthesia are a highly effective component of acute pain management.
With the advancement of ultrasonographic technology with higher resolution and penetration imaging, there is increasing use of ultrasonography (US) in acute and chronic pain blocks.
Recently, denervation therapy has been applied clinically for the treatment of intractable osteoarthritis (OA). This therapy provides an alternative for patients who are insensitive to conservative therapies or unwilling to receive surgery and general anesthesia. However, therapeutic effect of this method, especially the long-term efficacy, is still controversial.
Pain Physicians should consider nerve blocks when systemic analgesics are failing. (Adjuvant therapy)
Careful selection of patients
Benefits should outweigh the risks
Thorough knowledge of the limitations and side effects
Need for randomized controlled clinical trials.
Cancer hurts!
The misconception that a cancer patient is doomed to endure pain must be corrected. Cancer has pain and cancer pain has a cure. To manage cancer pain, we need to have a multidisciplinary approach.
Trauma is one of the primary causes of mortality and morbidity worldwide, and pain is the most common symptom reported by patients entering the Emergency Department. More than 5 million people in the United States report long-term disabilities due to traumatic injuries. Safe intraoperative care and effective acute pain management are essential for successful outcomes in the trauma patient.
Total knee replacement (TKR) is one of the most commonly done surgical procedures, with over 150,000 total knee replacements and THR performed annually in England and Wales in the National Health Service (NHS). In India although clear-cut data is not available but the incidence is increasing. In the US, 431,000 TKRs are performed yearly and the utilization of TKR has increased over the last two decades, especially among younger patients .TKR may be associated with severe post-operative pain. The International Association for the Study of Pain (IASP) has defined pain as “an unpleasant sensory or emotional experience associated with actual or potential tissue damage, or described in terms of such damage”. The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has made adequate pain management a priority and has deemed monitoring pain as the “fifth” vital sign.
Management of acute postoperative pain has revolutionized in recent decades. Fortunately, there is a great consensus regarding the benefits of pain control in the immediately postoperative period on morbidity and mortality of the surgical patients. Anaesthesiologists have a key role in this field.
Dr. Alan Kaye Shreveport is a leading Anesthesiologist, Pain Medicine Specialist and Interventional Pain Management Specialist with over 3 decades of experience. He has helped many thousands of people gain relief from acute and chronic pain through proven therapy methods, technology, and his wealth in education.
Anesthesia is a common term that you mostly here whenever a clinical treatment or surgery is being carried out. However, very few people know that several types of anesthesia exist that are administered according to the requirement of the invasive treatment.
Different types of anesthesia by john gerancherJohn Gerancher
Recognized as a pioneer in the field of anesthesiology, Dr. John Gerancher was responsible for developing the clinical care area, teaching program, and regional anesthesia section at Wake Forest Baptist Medical Center. Dr. John Gerancher also designed and implemented a computer information system for the operating room called the John Galt. Otherwise known to his peers as J.C., Dr. John Charles Gerancher was licensed to practice medicine in Washington, North Carolina, and California.
Austin Pain & Relief is an open access, peer reviewed, scholarly journal dedicated to publish articles covering all areas of Pain & Relief.
The journal aims to promote research communications and provide a forum for doctors, researchers, physicians and healthcare professionals to find most recent advances in all areas of Pain & Relief. Austin Pain & Relief accepts original research articles, reviews, mini reviews, case reports and rapid communication covering all aspects of pain and relief.
Austin Pain & Relief strongly supports the scientific up gradation and fortification in related scientific research community by enhancing access to peer reviewed scientific literary works. Austin Publishing Group also brings universally peer reviewed journals under one roof thereby promoting knowledge sharing, mutual promotion of multidisciplinary science.
A New York resident, Dr. Elliott Bennett-Guerrero has a doctor of medicine degree and is currently the professor and vice chairman in the Department of Anesthesiology at Stony Brook Medicine. Dr. Elliott Bennett-Guerrero led a clinical trial in which Stony Brook tested a new coronavirus treatment.
Convalescent blood plasma therapy was a proposed treatment for coronavirus patients. The therapy consists of transfusing plasma from a person that has recovered from an infection with coronavirus. The therapy was mostly used in patients that were hospitalized or those who recently developed the condition for a few days. Multiple studies showed that the therapy could increase desirable antibodies to COVID, but in general this was not very helpful in terms of likelihood of recovery from the infection or reduction in symptoms.
Dr. Elliott Bennett-Guerrero is a professor of anesthesiology and vice-chair for clinical research at Stony Brook Medicine. Some of Dr. Elliott Bennett-Guerrero's research work focuses on treatment methods for the coronavirus disease, and on the safety of blood transfusions.
Blood transfusions are generally safe; however, there is still a possibility of complications. One of such complications is the acute immune hemolytic reaction, in which a person's immune system resists the transfusion and produces antibodies that attack the blood cells. The hemolytic reaction occurs when the donor's blood cells are not compatible with those of the recipient patient. When the immune system fights back against the transfusion, it releases a substance that can damage and harm the kidneys.
Acute immune hemolytic reactions may cause symptoms such as fever, bloody urine, or even cause a person to faint. The symptoms may appear during the procedure, or after it ends, and in some cases, a few days after. In extreme cases, the reaction can result in significant damage to a person's internal organs, including acute kidney failure. However, the reaction may pass without major damage to the body system. Doctors treat mild hemolytic reactions with pain relievers such as acetaminophen and in some cases with medications that can prevent kidney failure. Complications like this can be avoided by carefully screening all blood before transfusion.
A respected clinician, dual board-certified in anesthesiology and critical care medicine, Elliott Bennett-Guerrero, MD, is a professor of anesthesiology at Stony Brook Medicine in New York. In addition, he also serves as vice chairman for clinical research and innovation in the department of anesthesiology. At Stony Brook, Dr. Elliott Bennett-Guerrero led a significant COVID-19-related randomized trial of convalescent plasma in COVID-19-infected hospitalized patients.
In 2021, over three peer-reviewed publications suggested that convalescent plasma could help people recover from COVID-19 infection better, while the viral strain of concern was SARS-CoV- 2. The majority of these publications did not compare the efficacy of convalescent plasma in disease treatment with standard plasma. To address this concern and solidify scientific evidence, a group of researchers in New York conducted a double-bind randomized control trial that compared COVID-19 patients who were recipients of convalescent plasma with another group of COVID-19 patients who received standard plasma. As mentioned in the study category, the patients were selected randomly.
Convalescent plasma is different from standard plasma because it is collected from people who have recovered from the virus. These people have a high level of anti-viral proteins called anti-COVID antibodies. Antibodies fight diseases by hampering viral replication and mitigating the rate of cellular infection by viruses. Plasma is a blood component free of red blood cells and platelets.
The researchers saw a significant increase in antibody levels in those who received convalescent plasma compared to those given regular standard plasma. The study, however, did not observe a significant improvement in clinical outcomes, although it may have been underpowered to show small improvements attributable to the plasma.
A graduate of Harvard Medical School, Dr. Elliott Bennett Guerrero is the vice chairman and a professor of Anesthesiology at Stony Brook Medicine. In this capacity, Elliott Bennett Guerrero led a clinical trial for a coronavirus treatment with blood plasma.
In 2020, Stony Brook Medicine conducted research to see if the administration of blood plasma from individuals that have survived an infection with coronavirus -19 (COVID-19) can help patients who are hospitalized with COVID-19 infection . Convalescent plasma contains antibodies to COVID-19 and was theorized to have potential to help people who have not yet mounted an immune response to the virus. The study found that the administration of convalescent plasma increased antibodies to the virus that causes COVID-19 infection, but did not improve patient's survival or other clinical outcomes.
This clinical trial's results were published in Critical Care Medicine, which is the official journal of the Society of Critical Care Medicine (SCCM). The SCCM is the largest organization dedicated to improving the care of critically ill patients. It has members in more than 100 countries. More information about the SCCM can be found at: https://www.sccm.org
A graduate of Harvard Medical School, Elliott Bennett-Guerrero is a professor and vice-chairman of Stony Brook Medicine's department of anesthesiology. Elliott Bennett-Guerrero has conducted several studies related to COVID-19 including the use of convalescent blood plasma. A randomized clinical trial he led was published in the journal Critical Care Medicine: Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial. Critical Care Medicine. 2021 Jul 1;49(7):1015-1025. PMID: 33870923.
Convalescent blood plasma treatment has been used for patients that have the COVID-19 virus, however, studies have not shown it to be beneficial in most hospitalized patients. It involves plasma transfusion from people who have already recovered from the condition. The treatment and therapy is likely to be most beneficial in people that are in the early stage of the condition or who have a weak immune system and cannot mount their own antibody response to the infection.
The therapy can have rare side effects and risks that include allergic reactions . Although it can have risks, there were more than 500,000 people treated in the United States with the therapy and few felt any side effects.
An experienced and active ICU physician, Elliott Bennett-Guerrero is also medical director for perioperative quality and patient safety at Stony Brook Medicine. Elliott Bennett-Guerrero has conducted studies in search of new coronavirus treatments.
Stony Brook Medicine conducted a study on whether convalescent blood plasma from people with a prior Covid-19 infection can be used to help others recover from it. The clinical trial was published in Critical Care Medicine, which is the official journal of the Society of Critical Care Medicine. In the trial, Stony Brook used a test to verify whether a person who had Covid-19 had a sufficient number of IgG and IgM antibodies for use in treatment. This test analyzes a drop of blood from a fingertip and offers results in approximately 15 minutes. The study then randomized hospitalized patients with COVID-19 infection to receive either 2 bags of this "convalescent" plasma or 2 bags of standard plasma (not high in antibodies to COVID-19. The study showed that this treatment increased antibodies to COVID-19 but it did not demonstrate an improvement in patient outcome.
An accomplished anesthesiologist, Dr. Elliott Bennett-Guerrero serves as both a professor and vice president of the Department of Anesthesiology, as well as medical director for Perioperative Quality and Patient Safety, at Stony Brook Medicine. In April 2020, Dr. Elliott Bennett-Guerrero initiated a clinical study on a potential cure for ill patients who have tested positive for COVID-19.
The rapid increase in mortality rate associated with the spread of the novel coronavirus infection has spurred the urgent need for research-driven therapies. In an effort to address this issue, researchers at Stony Brook Medicine revisited a century-old approach to treating infectious diseases known as convalescent plasma. This involves introducing antibody-rich plasma from a healthy patient (who had recovered from the virus) to a sick patient's blood serum to optimize immune response to the infection.
According to Dr. Elliott Bennett-Guerrero, the lead researcher, an infected patient may gain an immune system benefit enabling recovery from the illness through an antibody-rich plasma transfusion. He also added that the approach is potentially beneficial at the early stages of the disease, when patients are yet to develop sufficient levels of antibodies to fight the infection. This study was approved by the FDA on April 2, 2020.
A professor and vice chair for clinical research at Stony Brook School of Medicine, Dr. Elliott Bennett-Guerrero also serves as medical director of perioperative quality and patient safety in the Department of Anesthesiology. In his leadership role with the university, Dr. Elliott Bennett-Guerrero focuses a portion of his research on the safety and effectiveness of blood transfusions.
Despite the routine use of prophylactic systemic antibiotics, surgical-site infection continues to be associated with significant morbidity and cost after colorectal sur- gery. The gentamicin–collagen sponge, an implantable topical antibiotic agent, is approved for surgical implantation in 54 countries. Since 1985, more than 1 million patients have been treated with the sponges.
Some observational studies have reported that transfusion of red-cell units that have been stored for more than 2 to 3 weeks is associated with serious, even fatal, adverse events. Patients undergoingcardiac surgery may be especially vulnerable to the adverse effects of transfusion.
Perioperativebloodtransfusionsarecostlyandhavesafetyconcerns.Asa result, there have been multiple initiatives to reduce transfusion use. However, the degree to which perioperative transfusion rates vary among hospitals is unknown.
Objective Toassesshospital-levelvariationinuseofallogeneicredbloodcell(RBC), fresh-frozen plasma, and platelet transfusions in patients undergoing coronary artery bypass graft (CABG) surgery.
Despitetheroutineuseofprophylacticsystemicantibiotics,sternalwoundin- fection still occurs in 5% or more of cardiac surgical patients and is associated with signifi- cant excess morbidity, mortality, and cost. The gentamicin-collagen sponge, a surgically implantable topical antibiotic, is currently approved in 54 countries. A large, 2-center, ran- domized trial in Sweden reported in 2005 that the sponge reduced surgical site infection by 50% in cardiac patients.
An experienced anesthesiologist and perioperative specialist, Dr. Elliott Bennett-Guerrero recently accepted a position as professor and vice chair for clinical research and innovation at Stony Brook University School of Medicine. Complementing his professional work, Dr. Elliott Bennett-Guerrero has written several scholarly articles on blood transfusions in cardiac surgery.
A former participant in PBS’ Doctors’ Diaries, Dr. Elliott Bennett-Guerrero serves as the director of Perioperative Clinical Research at the Duke Clinical Research Institute. Dr. Elliott Bennett-Guerrero concurrently hosts lectures as a professor of anesthesiology at the Duke University School of Medicine.
For more than 10 years, Elliott Bennett-Guerrero, MD, has lectured on anesthesiology and directed perioperative research at Duke University. In addition to these responsibilities, Elliott Bennett-Guerrero has overseen several clinical studies as a principal investigator.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Immunity to Veterinary parasitic infections power point presentation
A Look at the Different Types of Anesthesia
1. A Look at the Different Types of
Anesthesia
Elliott Bennett-Guerrero
2. Introduction
Based in Stony Brook, New York, Dr. Elliott Bennett-Guerrero
leads the Department of Anesthesiology at Stony Brook
Medicine as the vice chair of clinical research and innovation.
Concurrent to this role, Dr. Elliott Bennett-Guerrero helps
educate the new generation of medical professionals as a
professor of anesthesiology.
When undergoing medical procedures, patients receive
anesthesia to minimize the pain. Anesthesiologists typically
choose to administer one of several types of anesthesia. To
make the right choice for each patient, anesthesiologists must
base their decision on numerous factors, including the
procedure and the health of the patient.
For minor procedures, most patients receive local anesthesia
to temporarily numb limited areas. This type of anesthesia can
come in the form of an injection, a spray, or a cream. Patients
who receive local anesthesia are usually awake during their
medical procedures.
3. Anesthesia
Anesthesiologists who treat patients with surgeries
of a larger scale may use regional anesthesia, which
blocks nerves affected by the surgical site. C-
sections and spinal surgeries commonly use regional
anesthesia.
Patients receive general anesthesia if they must be
unconscious during their surgical procedures.
Administered either through an inhalant or injection,
general anesthesia is crucial for surgeries that are
too severe for local or regional anesthesia. Patients
under general anesthesia must receive breathing
support while they sleep.